Man Group
UTMD icon

Man Group’s Utah Medical Products UTMD Stock Holding History

Man Group’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,146
Closed -$679K – 2211
2024
Q3 		$679K Buy
10,146
+865
+9% +$58.7K ﹤0.01% 1593
2024
Q2 		$620K Buy
9,281
+3,258
+54% +$222K ﹤0.01% 1625
2024
Q1 		$428K Buy
+6,023
New +$452K ﹤0.01% 1835
2023
Q3 		– Hold
0
– – – 1578
2022
Q1 		– Sell
-2,316
Closed -$232K – 2381
2021
Q4 		$232K Buy
+2,316
New +$236K ﹤0.01% 1756
2019
Q2 		– Sell
-3,889
Closed -$343K – 2011
2019
Q1 		$343K Sell
3,889
-1,100
-22% -$96.7K ﹤0.01% 1791
2018
Q4 		$414K Sell
4,989
-700
-12% -$61.6K ﹤0.01% 1669
2018
Q3 		$536K Sell
5,689
-1,011
-15% -$96.6K ﹤0.01% 1823
2018
Q2 		$738K Buy
+6,700
New +$700K ﹤0.01% 1693

Other funds holding UTMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Man Group's UTMD Position: Q4 2024 in Review

Man Group sold out of Utah Medical Products (UTMD) in Q4 2024, closing a stake of 10,146 shares — an estimated $679K sold.

Man Group first reported a position in UTMD in Q2 2018 and held it in 8 quarters. The position peaked at $738K in Q2 2018. 112 funds tracked by Wall St. Rank hold UTMD as of Q4 2024.

  • Man Group reported no remaining Utah Medical Products position as of Q4 2024 after selling out during the quarter.
  • Man Group sold 10,146 Utah Medical Products shares in Q4 2024, an estimated $679K.
  • Man Group first reported a position in Utah Medical Products in Q2 2018 and held it in 8 quarters.
  • Man Group's Utah Medical Products position peaked at $738K in Q2 2018.
  • 112 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2024.

Based on Man Group's 13F filing for Q4 2024, filed 14 Feb 2025.